HIF1A and systemic lupus erythematosus: Collectively, these findings suggest that modulating key factors within the HIF-1α signaling pathway, both upstream and downstream, can effectively optimize effector cell metabolism, diminish the proliferation and overactivation of abnormal, self-reactive cells, and subsequently ameliorate tissue inflammation in SLE patients, particularly those with LN.